Octreotide acetate Pen bulk supplier for pharma manufacturers

Octreotide Acetate Pen 2,500 mcg/mL prefilled pen Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 2,500 mcg/mL prefilled pen

Reference Brands: Bynfezia Pen (USA)

Octreotide (brand Sandostatin®) is used to treat carcinoid tumors, acromegaly, and GEP-NETs. Available in subcutaneous injections (0.5 mg/mL, 1 mg/mL, 3 mg/mL) and long-acting formulations (Sandostatin LAR®) (10 mg, 20 mg, 30 mg), it controls tumor-related symptoms like diarrhea and flushing by inhibiting hormone release. Available through GMP-compliant suppliers in the US and EU for oncology treatment.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Octreotide Acetate Pen? List it or send an offer →

Product Description:

Octreotide, marketed under the brand name Sandostatin®, is a somatostatin analogue used in oncology to manage carcinoid tumors, acromegaly, and gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Available as subcutaneous injections (0.5 mg/mL, 1 mg/mL, 3 mg/mL) and long-acting injections (Sandostatin LAR®) (10 mg, 20 mg, 30 mg), it works by inhibiting hormone secretion, controlling tumor-induced symptoms like diarrhea and flushing. Sourced from GMP-certified suppliers, Octreotide is widely available for global distribution in US and EU markets. It provides reliable therapeutic options for oncologists and healthcare providers treating complex neuroendocrine tumors.

Octreotide Acetate Pen — third party manufacturing & bulk supply

Octreotide Acetate Pen 2,500 mcg/mL prefilled pen is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Octreotide Acetate Pen is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Octreotide Acetate Pen listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Octreotide Acetate Pen →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

A prefilled, multi-dose pen of octreotide acetate for subcutaneous injection. The best-known example is Bynfezia Pen, approved in the US in 2020.

Bynfezia Pen is approved in the US. Tell us your market and we will check which octreotide pens and injections are registered there and how they can be supplied.

The same uses as octreotide injection in vials: acromegaly, and the severe diarrhoea and flushing caused by carcinoid tumours and VIP-secreting tumours.

See our main octreotide injection page for vials, depot formulations and octreotide API, or send us an RFQ with the product and market.